{"id":7223,"date":"2021-06-04T11:52:16","date_gmt":"2021-06-04T04:52:16","guid":{"rendered":"https:\/\/www.oucru.org\/?p=7223"},"modified":"2023-01-14T10:10:02","modified_gmt":"2023-01-14T03:10:02","slug":"evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb","status":"publish","type":"post","link":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/","title":{"rendered":"Evaluation of New Diagnostics for Active and Incident TB (ENDxTB)"},"content":{"rendered":"<p>To improve the diagnosis of all forms of TB at any age, the OUCRU TB team is participating in the international ENDxTB project, funded 2020 \u2013 2025 by NIH. We provide clinical experience and laboratory skills to evaluate field-ready diagnostic tests and platforms for TB in Vietnam, in collaboration with Pham Ngoc Thach Hospital and District TB Units in Ho Chi Minh City.<\/p>\n<p><strong>See more:<\/strong>\u00a0<a href=\"https:\/\/www.endxtb.com\/\">https:\/\/www.endxtb.com\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>\u00a0<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>To improve the diagnosis of all forms of TB at any age, the OUCRU TB team is participating in the international ENDxTB project, funded 2020 \u2013 2025 by NIH. We [&hellip;]<\/p>\n","protected":false},"author":28,"featured_media":7224,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":"","_wp_rev_ctl_limit":""},"categories":[79],"tags":[],"class_list":["post-7223","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Evaluation of New Diagnostics for Active and Incident TB (ENDxTB) - OUCRU<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/\" \/>\n<meta property=\"og:locale\" content=\"id_ID\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evaluation of New Diagnostics for Active and Incident TB (ENDxTB) - OUCRU\" \/>\n<meta property=\"og:description\" content=\"To improve the diagnosis of all forms of TB at any age, the OUCRU TB team is participating in the international ENDxTB project, funded 2020 \u2013 2025 by NIH. We [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/\" \/>\n<meta property=\"og:site_name\" content=\"OUCRU\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OUCRUVN\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-04T04:52:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-14T03:10:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oucru.org\/wp-content\/uploads\/2021\/06\/EndxTB_picture.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1922\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Chi Ngo Huyen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@OUCRU_Programme\" \/>\n<meta name=\"twitter:site\" content=\"@OUCRU_Programme\" \/>\n<meta name=\"twitter:label1\" content=\"Ditulis oleh\" \/>\n\t<meta name=\"twitter:data1\" content=\"Chi Ngo Huyen\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/\"},\"author\":{\"name\":\"Chi Ngo Huyen\",\"@id\":\"https:\/\/www.oucru.org\/id\/#\/schema\/person\/aa112afe961656747e505d29ce550b57\"},\"headline\":\"Evaluation of New Diagnostics for Active and Incident TB (ENDxTB)\",\"datePublished\":\"2021-06-04T04:52:16+00:00\",\"dateModified\":\"2023-01-14T03:10:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/\"},\"wordCount\":78,\"publisher\":{\"@id\":\"https:\/\/www.oucru.org\/id\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oucru.org\/wp-content\/uploads\/2021\/06\/EndxTB_picture.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"id\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/\",\"url\":\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/\",\"name\":\"Evaluation of New Diagnostics for Active and Incident TB (ENDxTB) - OUCRU\",\"isPartOf\":{\"@id\":\"https:\/\/www.oucru.org\/id\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oucru.org\/wp-content\/uploads\/2021\/06\/EndxTB_picture.jpg\",\"datePublished\":\"2021-06-04T04:52:16+00:00\",\"dateModified\":\"2023-01-14T03:10:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#breadcrumb\"},\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#primaryimage\",\"url\":\"https:\/\/www.oucru.org\/wp-content\/uploads\/2021\/06\/EndxTB_picture.jpg\",\"contentUrl\":\"https:\/\/www.oucru.org\/wp-content\/uploads\/2021\/06\/EndxTB_picture.jpg\",\"width\":2560,\"height\":1922},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.oucru.org\/id\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evaluation of New Diagnostics for Active and Incident TB (ENDxTB)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.oucru.org\/id\/#website\",\"url\":\"https:\/\/www.oucru.org\/id\/\",\"name\":\"OUCRU\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.oucru.org\/id\/#organization\"},\"alternateName\":\"Oxford University Clinical Research Unit (OUCRU)\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.oucru.org\/id\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"id\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.oucru.org\/id\/#organization\",\"name\":\"Oxford University Clinical Research Unit.\",\"alternateName\":\"OUCRU\",\"url\":\"https:\/\/www.oucru.org\/id\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png\",\"contentUrl\":\"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png\",\"width\":512,\"height\":333,\"caption\":\"Oxford University Clinical Research Unit.\"},\"image\":{\"@id\":\"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/OUCRUVN\/\",\"https:\/\/x.com\/OUCRU_Programme\",\"https:\/\/www.linkedin.com\/company\/oucru\/\",\"https:\/\/www.youtube.com\/@oxforduniversityclinicalre6618\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.oucru.org\/id\/#\/schema\/person\/aa112afe961656747e505d29ce550b57\",\"name\":\"Chi Ngo Huyen\",\"url\":\"https:\/\/www.oucru.org\/id\/author\/chinh\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evaluation of New Diagnostics for Active and Incident TB (ENDxTB) - OUCRU","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/","og_locale":"id_ID","og_type":"article","og_title":"Evaluation of New Diagnostics for Active and Incident TB (ENDxTB) - OUCRU","og_description":"To improve the diagnosis of all forms of TB at any age, the OUCRU TB team is participating in the international ENDxTB project, funded 2020 \u2013 2025 by NIH. We [&hellip;]","og_url":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/","og_site_name":"OUCRU","article_publisher":"https:\/\/www.facebook.com\/OUCRUVN\/","article_published_time":"2021-06-04T04:52:16+00:00","article_modified_time":"2023-01-14T03:10:02+00:00","og_image":[{"width":2560,"height":1922,"url":"https:\/\/www.oucru.org\/wp-content\/uploads\/2021\/06\/EndxTB_picture.jpg","type":"image\/jpeg"}],"author":"Chi Ngo Huyen","twitter_card":"summary_large_image","twitter_creator":"@OUCRU_Programme","twitter_site":"@OUCRU_Programme","twitter_misc":{"Ditulis oleh":"Chi Ngo Huyen"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#article","isPartOf":{"@id":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/"},"author":{"name":"Chi Ngo Huyen","@id":"https:\/\/www.oucru.org\/id\/#\/schema\/person\/aa112afe961656747e505d29ce550b57"},"headline":"Evaluation of New Diagnostics for Active and Incident TB (ENDxTB)","datePublished":"2021-06-04T04:52:16+00:00","dateModified":"2023-01-14T03:10:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/"},"wordCount":78,"publisher":{"@id":"https:\/\/www.oucru.org\/id\/#organization"},"image":{"@id":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oucru.org\/wp-content\/uploads\/2021\/06\/EndxTB_picture.jpg","articleSection":["News"],"inLanguage":"id"},{"@type":"WebPage","@id":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/","url":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/","name":"Evaluation of New Diagnostics for Active and Incident TB (ENDxTB) - OUCRU","isPartOf":{"@id":"https:\/\/www.oucru.org\/id\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#primaryimage"},"image":{"@id":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oucru.org\/wp-content\/uploads\/2021\/06\/EndxTB_picture.jpg","datePublished":"2021-06-04T04:52:16+00:00","dateModified":"2023-01-14T03:10:02+00:00","breadcrumb":{"@id":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#breadcrumb"},"inLanguage":"id","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/"]}]},{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#primaryimage","url":"https:\/\/www.oucru.org\/wp-content\/uploads\/2021\/06\/EndxTB_picture.jpg","contentUrl":"https:\/\/www.oucru.org\/wp-content\/uploads\/2021\/06\/EndxTB_picture.jpg","width":2560,"height":1922},{"@type":"BreadcrumbList","@id":"https:\/\/www.oucru.org\/id\/evaluation-of-new-diagnostics-for-active-and-incident-tb-endxtb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oucru.org\/id\/"},{"@type":"ListItem","position":2,"name":"Evaluation of New Diagnostics for Active and Incident TB (ENDxTB)"}]},{"@type":"WebSite","@id":"https:\/\/www.oucru.org\/id\/#website","url":"https:\/\/www.oucru.org\/id\/","name":"OUCRU","description":"","publisher":{"@id":"https:\/\/www.oucru.org\/id\/#organization"},"alternateName":"Oxford University Clinical Research Unit (OUCRU)","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oucru.org\/id\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"id"},{"@type":"Organization","@id":"https:\/\/www.oucru.org\/id\/#organization","name":"Oxford University Clinical Research Unit.","alternateName":"OUCRU","url":"https:\/\/www.oucru.org\/id\/","logo":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/","url":"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png","contentUrl":"https:\/\/www.oucru.org\/wp-content\/uploads\/2023\/02\/cropped-cropped-oucru-logo.png","width":512,"height":333,"caption":"Oxford University Clinical Research Unit."},"image":{"@id":"https:\/\/www.oucru.org\/id\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OUCRUVN\/","https:\/\/x.com\/OUCRU_Programme","https:\/\/www.linkedin.com\/company\/oucru\/","https:\/\/www.youtube.com\/@oxforduniversityclinicalre6618"]},{"@type":"Person","@id":"https:\/\/www.oucru.org\/id\/#\/schema\/person\/aa112afe961656747e505d29ce550b57","name":"Chi Ngo Huyen","url":"https:\/\/www.oucru.org\/id\/author\/chinh\/"}]}},"_links":{"self":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/posts\/7223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/comments?post=7223"}],"version-history":[{"count":1,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/posts\/7223\/revisions"}],"predecessor-version":[{"id":16175,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/posts\/7223\/revisions\/16175"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/media\/7224"}],"wp:attachment":[{"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/media?parent=7223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/categories?post=7223"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oucru.org\/id\/wp-json\/wp\/v2\/tags?post=7223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}